A Study of Ixekizumab (LY2439821) in Participants aged ≥18 Years with Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Trial Identifier: 18528
Sponsor: Eli Lilly and Company
Start Date: June 2023
Primary Completion Date: August 2024
Study Completion Date: September 2024
Condition: Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary

Trial Locations

Country Location
India, Andhra Pradesh Vizag, Andhra Pradesh, India, 530002
India, Chhattisgarh Raipur, Chhattisgarh, India, 492099
India, Gujarat Ahmedabad, Gujarat, India, 380015
India, Gujarat Ahmedabad, Gujarat, India, 380016
India, Gujarat Ahmedabad, Gujarat, India, 380060
India, Gujarat Ahmedabad, Gujarat, India, 380006
India, Gujarat Surat, Gujarat, India, 395001
India, Karnataka Mangalore, Karnataka, India, 575002
India, Maharashtra Navi Mumbai, Maharashtra, India, 400706
India, Maharashtra Pune, Maharashtra, India, 411001
India, Maharashtra Pune, Maharashtra, India, 411005
India, Punjab Chandigarh, Punjab, India, 160012
India, West Bengal Kolkata, West Bengal, India, 700073
India, West Bengal Kolkata, West Bengal, India, 700017